Earnings History Data for GeoVax Labs, Inc. (GOVX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

GeoVax Labs, Inc.

GeoVax Labs Inc. is a clinical-stage biotechnology company. It engages in developing human vaccines against infectious diseases and cancer using a novel patented Modified Vaccinia Ankara-Virus Like Particle based vaccine platform. GeoVax Labs Inc. is based in ATLANTA, GA.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
11-11-2021 AH 5:00 PM ET
(Nov 11)
GOVX GeoVax Labs, Inc. 26.51 -0.31 0.00 -0.73 GeoVax EPS beats by $0.06
[11/11/2021 4:10 PM]
3.88 0.03 
(0.78%)
3.86 0.01 
(0.26%)
2.56 - 8.71 83,753 270,000 1,695
11-08-2021 AH 5:00 PM ET
(Aug 11)
GOVX GeoVax Labs, Inc. 28.73 -0.21 0.00 -0.60 GeoVax EPS beats by $0.22
[8/11/2021 4:26 PM]
4.09 -0.16 
(-3.69%)
4.30 0.06 
(1.30%)
2.56 - 12.60 425,672 600,000 5,455
06-05-2021 AH 5:00 PM ET
(May 6)
GOVX GeoVax Labs, Inc. 38.97 -0.29 0.00 -2.60 GeoVax reports Q1 results
[5/6/2021 4:38 PM]
5.95 -0.35 
(-5.56%)
5.80 -0.50 
(-7.94%)
2.56 - 35.00 490,277 640,000 18,244
05-11-2020 AH GOVX GeoVax Labs, Inc. 10.29 -0.73 0.00 -99.99 GeoVax reports Q3 results
[11/5/2020 5:51 PM]
2.81 -0.09 
(-3.10%)
2.85 -0.05 
(-1.72%)
2.30 - 68.00 192,636 2,422,106 3,250